This document from the European Anaphylaxis Taskforce provides information and guidance on anaphylaxis and anaphylactoid reactions. It defines anaphylaxis and anaphylactoid reactions, discusses evaluation and management of patients with a history of anaphylaxis, and provides information on common triggers including foods, insect stings, medications, and other allergens. It emphasizes the importance of recognizing signs and symptoms of anaphylaxis promptly and treating it aggressively to prevent severe outcomes. Specialist consultation is recommended to determine triggers and educate patients on avoidance and emergency treatment.
Anaphylaxis is a severe allergic reaction that affects multiple body systems. It can be caused by medications like muscle relaxants, antibiotics, and opioids during surgery. Common symptoms include low blood pressure, rashes, and breathing difficulties. Muscle relaxants are the most frequent cause of anaphylaxis during procedures. While rare, allergic reactions to substances like latex gloves, egg products in propofol, and preservatives in local anesthetics are also possible. Testing can identify specific allergies to help select safer alternatives for future medical care.
This document provides information about anaphylaxis including its definition, types, causes, signs and symptoms, evaluation, treatment, and prognosis. Anaphylaxis is a severe, potentially life-threatening allergic reaction affecting multiple body systems. It can be triggered by foods, medications, insect stings, or latex. Treatment involves epinephrine, fluids, airway management, oxygen, antihistamines, steroids, and monitoring for biphasic reactions. Refractory anaphylaxis may require vasopressors, methylene blue, or extracorporeal membrane oxygenation. Prognosis is generally excellent if the trigger can be avoided.
Anaphylaxis is an acute, multi organ, life threatening allergic reaction. Initial symptoms may look like a normal allergy with runny nose or rash and usually occur within minutes of exposure to an allergen. Within a few minutes, symptoms get more severe and can be deadly if not treated. Anaphylaxis requires immediate medical attention.
The document provides information about anaphylaxis including its definition, triggers, risk factors, types of reactions, pathophysiology, signs and symptoms, and diagnostic criteria. Anaphylaxis is a severe, life-threatening allergic reaction that requires prompt medical treatment. Common triggers include foods, medications, insect stings, and latex. Reactions can be uni-phasic, protracted, or bi-phasic. The pathophysiology involves the release of inflammatory mediators from mast cells and basophils via IgE-mediated or non-IgE mediated mechanisms. Signs and symptoms affect multiple organ systems and can include skin issues, respiratory distress, gastrointestinal symptoms and cardiovascular or neurological problems.
The document discusses anaphylaxis and anaphylactic shock during anesthesia. It begins by describing the discovery of anaphylaxis in 1902 and defines anaphylaxis as a severe, systemic allergic reaction involving two or more organ systems that can be life-threatening. Anaphylactic shock is a severe allergic reaction leading to sudden cardiovascular collapse. Common causes of anaphylactic reactions during anesthesia include muscle relaxants, induction drugs, local anesthetics, opioids, and other medications. The mechanism involves IgE antibodies and mast cell degranulation releasing chemical mediators like histamine that cause symptoms. Prompt treatment is critical in an emergency situation.
Charles Robert Richet and Paul Portier coined the term "anaphylaxis" in 1902 to describe a dog's fatal reaction to repeated injections of jellyfish toxin. Anaphylaxis is a type I hypersensitivity reaction mediated by IgE antibodies that causes symptoms such as low blood pressure, rashes, and breathing difficulties upon reexposure to an antigen. Perioperative anaphylaxis is difficult to diagnose due to masking by anesthesia drugs and procedures. Treatment involves epinephrine, oxygen, fluids, steroids, and bronchodilators. Muscle relaxants are a common cause, while antibiotics, latex, and protamine also carry risks. Thorough history screening and allergy testing can help prevent severe anaph
The 12-year-old boy was stung by a bee and began experiencing symptoms of anaphylaxis including shortness of breath, wheezing, weakness, and dizziness. At the emergency department, he was found to have low blood pressure, rapid heart rate, respiratory distress, urticaria, and pale appearance. He was treated with epinephrine, antihistamines, steroids, and fluids, which resolved his symptoms. He was discharged with oral medications and instructed to follow up. Anaphylaxis is a severe, potentially life-threatening allergic reaction caused by the release of chemicals from mast cells and basophils.
The document discusses anaphylaxis, including its causes, risk factors, symptoms, prevention, and treatment. It causes include IgE-mediated reactions to foods, drugs, insects, as well as non-IgE mediated reactions. Symptom onset is usually within 5-30 minutes. Prevention involves avoiding allergens and carrying epinephrine. Treatment involves epinephrine, antihistamines, corticosteroids, and monitoring for biphasic reactions. Drug allergies can also cause anaphylaxis and involve skin testing to identify culprit drugs when possible. Management includes avoidance, alternative medications, and potential desensitization.
Anaphylaxis is a severe allergic reaction that affects multiple body systems. It can be caused by medications like muscle relaxants, antibiotics, and opioids during surgery. Common symptoms include low blood pressure, rashes, and breathing difficulties. Muscle relaxants are the most frequent cause of anaphylaxis during procedures. While rare, allergic reactions to substances like latex gloves, egg products in propofol, and preservatives in local anesthetics are also possible. Testing can identify specific allergies to help select safer alternatives for future medical care.
This document provides information about anaphylaxis including its definition, types, causes, signs and symptoms, evaluation, treatment, and prognosis. Anaphylaxis is a severe, potentially life-threatening allergic reaction affecting multiple body systems. It can be triggered by foods, medications, insect stings, or latex. Treatment involves epinephrine, fluids, airway management, oxygen, antihistamines, steroids, and monitoring for biphasic reactions. Refractory anaphylaxis may require vasopressors, methylene blue, or extracorporeal membrane oxygenation. Prognosis is generally excellent if the trigger can be avoided.
Anaphylaxis is an acute, multi organ, life threatening allergic reaction. Initial symptoms may look like a normal allergy with runny nose or rash and usually occur within minutes of exposure to an allergen. Within a few minutes, symptoms get more severe and can be deadly if not treated. Anaphylaxis requires immediate medical attention.
The document provides information about anaphylaxis including its definition, triggers, risk factors, types of reactions, pathophysiology, signs and symptoms, and diagnostic criteria. Anaphylaxis is a severe, life-threatening allergic reaction that requires prompt medical treatment. Common triggers include foods, medications, insect stings, and latex. Reactions can be uni-phasic, protracted, or bi-phasic. The pathophysiology involves the release of inflammatory mediators from mast cells and basophils via IgE-mediated or non-IgE mediated mechanisms. Signs and symptoms affect multiple organ systems and can include skin issues, respiratory distress, gastrointestinal symptoms and cardiovascular or neurological problems.
The document discusses anaphylaxis and anaphylactic shock during anesthesia. It begins by describing the discovery of anaphylaxis in 1902 and defines anaphylaxis as a severe, systemic allergic reaction involving two or more organ systems that can be life-threatening. Anaphylactic shock is a severe allergic reaction leading to sudden cardiovascular collapse. Common causes of anaphylactic reactions during anesthesia include muscle relaxants, induction drugs, local anesthetics, opioids, and other medications. The mechanism involves IgE antibodies and mast cell degranulation releasing chemical mediators like histamine that cause symptoms. Prompt treatment is critical in an emergency situation.
Charles Robert Richet and Paul Portier coined the term "anaphylaxis" in 1902 to describe a dog's fatal reaction to repeated injections of jellyfish toxin. Anaphylaxis is a type I hypersensitivity reaction mediated by IgE antibodies that causes symptoms such as low blood pressure, rashes, and breathing difficulties upon reexposure to an antigen. Perioperative anaphylaxis is difficult to diagnose due to masking by anesthesia drugs and procedures. Treatment involves epinephrine, oxygen, fluids, steroids, and bronchodilators. Muscle relaxants are a common cause, while antibiotics, latex, and protamine also carry risks. Thorough history screening and allergy testing can help prevent severe anaph
The 12-year-old boy was stung by a bee and began experiencing symptoms of anaphylaxis including shortness of breath, wheezing, weakness, and dizziness. At the emergency department, he was found to have low blood pressure, rapid heart rate, respiratory distress, urticaria, and pale appearance. He was treated with epinephrine, antihistamines, steroids, and fluids, which resolved his symptoms. He was discharged with oral medications and instructed to follow up. Anaphylaxis is a severe, potentially life-threatening allergic reaction caused by the release of chemicals from mast cells and basophils.
The document discusses anaphylaxis, including its causes, risk factors, symptoms, prevention, and treatment. It causes include IgE-mediated reactions to foods, drugs, insects, as well as non-IgE mediated reactions. Symptom onset is usually within 5-30 minutes. Prevention involves avoiding allergens and carrying epinephrine. Treatment involves epinephrine, antihistamines, corticosteroids, and monitoring for biphasic reactions. Drug allergies can also cause anaphylaxis and involve skin testing to identify culprit drugs when possible. Management includes avoidance, alternative medications, and potential desensitization.
This document provides information on the treatment of anaphylaxis. It begins by defining anaphylaxis as an acute hypersensitivity reaction and describes the pathophysiology involving the release of histamine. The mainstay treatment is identified as adrenaline (epinephrine) injected intramuscularly. Common causes and signs/symptoms are outlined involving the airways, breathing and circulation. Additional treatment steps are described including IV fluids, antihistamines, steroids, and monitoring. Guidance is provided on discharge instructions and managing pediatric cases.
This document discusses anaphylactic shock, including:
- Definitions of anaphylaxis and anaphylactoid reactions.
- The pathophysiology of anaphylaxis, which involves mast cell and basophil activation leading to mediator release and various symptoms.
- Etiologies of anaphylaxis including allergens, foods, drugs, and other causes.
- Clinical manifestations across multiple organ systems like skin, respiratory, cardiovascular and more.
- Diagnosis, prevention, and management, which focuses on epinephrine administration, airway management, fluids, and adjunctive treatments.
an extreme, often life-threatening allergic reaction to an antigen to which the body has become hypersensitive.,an extreme, often life-threatening allergic reaction to an antigen to which the body has become hypersensitive.
Acute anaphylaxis and anaphylactic reactionsdani raad
this presentation speak about Acute anaphylaxis and anaphylactic reactions and their definitions , symptoms , diagnosis , treatment , all informations are in brief
Prof. mridul Panditrao explains his ideas about the anaphylactic reactions in the peri-operative( pre, intra and post) period, how to diagnose them, treat them and also to prevent them.
Peri-operative anaphylaxis can occur in response to many drugs used during anesthesia like neuromuscular blocking agents (NMBAs), antibiotics, colloids, and hypnotics. NMBAs are the most common cause. Diagnosis involves considering the time of reaction, drug history, tryptase levels and diagnostic tests like skin tests. While challenging to diagnose, it is important to identify causative agents to avoid severe reactions during future procedures. Proper history taking and diagnostic evaluation can help determine risk factors and manage patients experiencing peri-operative anaphylaxis.
Anaphylactic and anaphylactoid reactions are severe allergic reactions that can be life-threatening. Anaphylactic reactions are caused by immunoglobulin E or G antibodies responding to a previously encountered antigen. Anaphylactoid reactions have similar symptoms but are caused by non-antibody related mechanisms during first exposure. Common allergens that can trigger these reactions include foods, insect stings, pollen, medications like antibiotics, and contrast agents used in imaging. Treatment involves stopping exposure, monitoring vital signs, compensating fluid loss, and administering epinephrine which constricts blood vessels and stimulates the heart.
Immune System Disorders - Anaphylaxis, Angioedema, Drug AllergiesZach Jarou
This document discusses immune system disorders categorized into 4 sections: collagen vascular disease, hypersensitivity, transplant-related problems, and immune complex disorders. It summarizes 16 common immune disorders and correlates them to the Gell and Coombs classification system. Key points covered include definitions of anaphylaxis, common allergens, treatment with epinephrine, and discussions of biphasic reactions. Other sections summarize drug allergies such as penicillin cross-reactivity and contrast media reactions. Overall, the document provides a high-level overview of common immune system disorders encountered in emergency medicine.
Anaphylaxis is a serious allergic reaction that affects multiple body systems. It is caused by exposure to an allergen that is absorbed systemically such as foods or medications. The allergen activates mast cells to release inflammatory mediators like histamine that cause symptoms. Symptoms can include skin issues, respiratory distress, gastrointestinal problems, and cardiovascular collapse. Treatment involves epinephrine injection, antihistamines, oxygen, corticosteroids, and addressing airway and circulatory problems. Prevention relies on allergen avoidance and carrying epinephrine auto-injectors. Prompt treatment improves outcomes.
This document provides information on anaphylaxis including its definition, clinical criteria, causes, pathophysiology, clinical features, diagnosis, differential diagnosis, and management. Anaphylaxis is defined as a serious allergic reaction that is rapid in onset and can cause death. It is caused by exposure to an allergen in sensitized individuals and involves the release of mediators from mast cells and basophils like histamine. Symptoms may include skin issues, low blood pressure, respiratory distress, and gastrointestinal symptoms. Epinephrine is the first line treatment to reverse its effects.
This document discusses allergies and anaphylaxis, including their pathophysiology, assessment findings, and management. It describes anaphylaxis as a life-threatening allergic reaction caused by exposure to an allergen, which results in widespread histamine release and affects multiple body systems. Key treatments for anaphylaxis include epinephrine, antihistamines, corticosteroids, oxygen, IV fluids and airway management. Allergic reactions involve similar symptoms but are typically less severe. Patient education focuses on prevention, recognition of symptoms and self-treatment options.
To watch my animated viedo on YouTube visit
http://www.youtube.com/watch?v=nVHDGWfQhSU
To download my animated presentation visit:
https://www.dropbox.com/s/bbtayufrn1clnvh/Anaphylaxis.pptx
This document defines anaphylaxis and outlines its diagnostic criteria. Anaphylaxis is a serious allergic reaction that is rapid in onset and can cause death. There are three diagnostic criteria for anaphylaxis, which reflect different clinical presentations. Criterion 1 requires involvement of the skin, mucosal tissues, or both, and either respiratory compromise or reduced blood pressure. Criterion 2 requires two or more symptoms from skin, respiratory, or cardiovascular systems. Criterion 3 requires reduced blood pressure after exposure to a known allergen. The diagnostic criteria are intended to identify at least 80% of anaphylactic reactions based on their symptoms.
This presentation was designed as a summation of what Anaphylaxis is, the signs and symptoms to be aware of, and common causes. This presentation is not intended to replace medical advice or act as an emergency management plan. It is simply a guide for those who know little about Anaphylaxis, or those who just need a refresher! AllergyAble is committed to educating the allergic community and helping them create allergy-friendly environments. As always we aim to help people with allergies live better lives, at home, at work and at play!
Credit to Anaphylaxis Canada for the use of think F.A.S.T. terminology.
Anaphylaxis is a severe allergic reaction that can be life-threatening. The document discusses the pathophysiology of anaphylaxis including the role of basophils and mast cells in releasing inflammatory mediators like histamine. Signs and symptoms involve multiple organ systems like the skin, respiratory and cardiovascular systems. Management involves adrenaline injection, oxygen, fluids and monitoring for biphasic reactions.
IMMUNOLOGY (ALLERGIC REACTIONS AND ANAPHYLAXIS)djorgenmorris
This document discusses allergies and anaphylaxis, including the pathophysiology of the immune system response, assessment findings for anaphylaxis, and management of anaphylactic and allergic reactions. It describes how exposure to an antigen causes the immune system to produce antibodies, and future exposures result in a more rapid response. In anaphylaxis, exposure to an allergen causes massive histamine release, resulting in airway constriction, drop in blood pressure, and other dangerous symptoms. Paramedics are trained to manage anaphylaxis through protecting the airway, administering epinephrine and other medications, giving fluids, and providing psychological support and patient education.
Anaphylaxis is a severe, potentially life-threatening allergic reaction affecting multiple organs. It is considered present when there is acute onset of symptoms involving the skin and mucosa along with respiratory or cardiovascular symptoms, or just two or more symptoms rapidly after exposure to a trigger. Adrenaline is the first line treatment and should be administered immediately to prevent progression of symptoms. Antihistamines and steroids are adjunctive but do not treat the underlying cause. Patients require monitoring for biphasic reactions and should receive training and a prescription for epinephrine auto-injectors for future reactions.
This document provides information about allergic reactions and anaphylaxis, including causes of death, pathophysiology, clinical manifestations, management, and case presentations. Key points:
- Laryngeal edema and bronchospasm account for over 70% of anaphylaxis deaths
- Mast cell degranulation releases histamine and other mediators causing symptoms like bronchospasm, hypotension, edema
- Treatment depends on severity but includes epinephrine, H1 antihistamines, corticosteroids, fluids
- Disposition is observation for 6-8 hours regardless of response to treatment due to risk of biphasic reaction
Anaphylaxis and anaphylactoid reactions docBhanu Sharadha
The document provides information from the European Anaphylaxis Taskforce on anaphylaxis and anaphylactoid reactions. It defines anaphylaxis and anaphylactoid reactions, discusses the evaluation and management of patients with a history of anaphylaxis, and covers various triggers of anaphylaxis including foods, insect stings, medications, and others. It emphasizes the importance of recognizing anaphylactic events rapidly and treating them promptly to prevent severe outcomes. Consultation with an allergy specialist is recommended to properly evaluate triggers and educate patients.
Si el envenenamiento es reconocido de forma temprana y reciben una atención medica adecuada, el pronostico es favorable.
La exposición a toxinas puede ocurrir por accidente (es decir, incidentes o interacciones medicamentosas) o intencionalmente (es decir, el abuso de sustancias o ingestas intencionales).
El envenenamiento depende de numerosos factores, como el tipo de sustancia, la dosis, el tiempo de exposición a la presentación a un centro de atención a la salud y el estado de salud preexistente del paciente.
This document provides information on the treatment of anaphylaxis. It begins by defining anaphylaxis as an acute hypersensitivity reaction and describes the pathophysiology involving the release of histamine. The mainstay treatment is identified as adrenaline (epinephrine) injected intramuscularly. Common causes and signs/symptoms are outlined involving the airways, breathing and circulation. Additional treatment steps are described including IV fluids, antihistamines, steroids, and monitoring. Guidance is provided on discharge instructions and managing pediatric cases.
This document discusses anaphylactic shock, including:
- Definitions of anaphylaxis and anaphylactoid reactions.
- The pathophysiology of anaphylaxis, which involves mast cell and basophil activation leading to mediator release and various symptoms.
- Etiologies of anaphylaxis including allergens, foods, drugs, and other causes.
- Clinical manifestations across multiple organ systems like skin, respiratory, cardiovascular and more.
- Diagnosis, prevention, and management, which focuses on epinephrine administration, airway management, fluids, and adjunctive treatments.
an extreme, often life-threatening allergic reaction to an antigen to which the body has become hypersensitive.,an extreme, often life-threatening allergic reaction to an antigen to which the body has become hypersensitive.
Acute anaphylaxis and anaphylactic reactionsdani raad
this presentation speak about Acute anaphylaxis and anaphylactic reactions and their definitions , symptoms , diagnosis , treatment , all informations are in brief
Prof. mridul Panditrao explains his ideas about the anaphylactic reactions in the peri-operative( pre, intra and post) period, how to diagnose them, treat them and also to prevent them.
Peri-operative anaphylaxis can occur in response to many drugs used during anesthesia like neuromuscular blocking agents (NMBAs), antibiotics, colloids, and hypnotics. NMBAs are the most common cause. Diagnosis involves considering the time of reaction, drug history, tryptase levels and diagnostic tests like skin tests. While challenging to diagnose, it is important to identify causative agents to avoid severe reactions during future procedures. Proper history taking and diagnostic evaluation can help determine risk factors and manage patients experiencing peri-operative anaphylaxis.
Anaphylactic and anaphylactoid reactions are severe allergic reactions that can be life-threatening. Anaphylactic reactions are caused by immunoglobulin E or G antibodies responding to a previously encountered antigen. Anaphylactoid reactions have similar symptoms but are caused by non-antibody related mechanisms during first exposure. Common allergens that can trigger these reactions include foods, insect stings, pollen, medications like antibiotics, and contrast agents used in imaging. Treatment involves stopping exposure, monitoring vital signs, compensating fluid loss, and administering epinephrine which constricts blood vessels and stimulates the heart.
Immune System Disorders - Anaphylaxis, Angioedema, Drug AllergiesZach Jarou
This document discusses immune system disorders categorized into 4 sections: collagen vascular disease, hypersensitivity, transplant-related problems, and immune complex disorders. It summarizes 16 common immune disorders and correlates them to the Gell and Coombs classification system. Key points covered include definitions of anaphylaxis, common allergens, treatment with epinephrine, and discussions of biphasic reactions. Other sections summarize drug allergies such as penicillin cross-reactivity and contrast media reactions. Overall, the document provides a high-level overview of common immune system disorders encountered in emergency medicine.
Anaphylaxis is a serious allergic reaction that affects multiple body systems. It is caused by exposure to an allergen that is absorbed systemically such as foods or medications. The allergen activates mast cells to release inflammatory mediators like histamine that cause symptoms. Symptoms can include skin issues, respiratory distress, gastrointestinal problems, and cardiovascular collapse. Treatment involves epinephrine injection, antihistamines, oxygen, corticosteroids, and addressing airway and circulatory problems. Prevention relies on allergen avoidance and carrying epinephrine auto-injectors. Prompt treatment improves outcomes.
This document provides information on anaphylaxis including its definition, clinical criteria, causes, pathophysiology, clinical features, diagnosis, differential diagnosis, and management. Anaphylaxis is defined as a serious allergic reaction that is rapid in onset and can cause death. It is caused by exposure to an allergen in sensitized individuals and involves the release of mediators from mast cells and basophils like histamine. Symptoms may include skin issues, low blood pressure, respiratory distress, and gastrointestinal symptoms. Epinephrine is the first line treatment to reverse its effects.
This document discusses allergies and anaphylaxis, including their pathophysiology, assessment findings, and management. It describes anaphylaxis as a life-threatening allergic reaction caused by exposure to an allergen, which results in widespread histamine release and affects multiple body systems. Key treatments for anaphylaxis include epinephrine, antihistamines, corticosteroids, oxygen, IV fluids and airway management. Allergic reactions involve similar symptoms but are typically less severe. Patient education focuses on prevention, recognition of symptoms and self-treatment options.
To watch my animated viedo on YouTube visit
http://www.youtube.com/watch?v=nVHDGWfQhSU
To download my animated presentation visit:
https://www.dropbox.com/s/bbtayufrn1clnvh/Anaphylaxis.pptx
This document defines anaphylaxis and outlines its diagnostic criteria. Anaphylaxis is a serious allergic reaction that is rapid in onset and can cause death. There are three diagnostic criteria for anaphylaxis, which reflect different clinical presentations. Criterion 1 requires involvement of the skin, mucosal tissues, or both, and either respiratory compromise or reduced blood pressure. Criterion 2 requires two or more symptoms from skin, respiratory, or cardiovascular systems. Criterion 3 requires reduced blood pressure after exposure to a known allergen. The diagnostic criteria are intended to identify at least 80% of anaphylactic reactions based on their symptoms.
This presentation was designed as a summation of what Anaphylaxis is, the signs and symptoms to be aware of, and common causes. This presentation is not intended to replace medical advice or act as an emergency management plan. It is simply a guide for those who know little about Anaphylaxis, or those who just need a refresher! AllergyAble is committed to educating the allergic community and helping them create allergy-friendly environments. As always we aim to help people with allergies live better lives, at home, at work and at play!
Credit to Anaphylaxis Canada for the use of think F.A.S.T. terminology.
Anaphylaxis is a severe allergic reaction that can be life-threatening. The document discusses the pathophysiology of anaphylaxis including the role of basophils and mast cells in releasing inflammatory mediators like histamine. Signs and symptoms involve multiple organ systems like the skin, respiratory and cardiovascular systems. Management involves adrenaline injection, oxygen, fluids and monitoring for biphasic reactions.
IMMUNOLOGY (ALLERGIC REACTIONS AND ANAPHYLAXIS)djorgenmorris
This document discusses allergies and anaphylaxis, including the pathophysiology of the immune system response, assessment findings for anaphylaxis, and management of anaphylactic and allergic reactions. It describes how exposure to an antigen causes the immune system to produce antibodies, and future exposures result in a more rapid response. In anaphylaxis, exposure to an allergen causes massive histamine release, resulting in airway constriction, drop in blood pressure, and other dangerous symptoms. Paramedics are trained to manage anaphylaxis through protecting the airway, administering epinephrine and other medications, giving fluids, and providing psychological support and patient education.
Anaphylaxis is a severe, potentially life-threatening allergic reaction affecting multiple organs. It is considered present when there is acute onset of symptoms involving the skin and mucosa along with respiratory or cardiovascular symptoms, or just two or more symptoms rapidly after exposure to a trigger. Adrenaline is the first line treatment and should be administered immediately to prevent progression of symptoms. Antihistamines and steroids are adjunctive but do not treat the underlying cause. Patients require monitoring for biphasic reactions and should receive training and a prescription for epinephrine auto-injectors for future reactions.
This document provides information about allergic reactions and anaphylaxis, including causes of death, pathophysiology, clinical manifestations, management, and case presentations. Key points:
- Laryngeal edema and bronchospasm account for over 70% of anaphylaxis deaths
- Mast cell degranulation releases histamine and other mediators causing symptoms like bronchospasm, hypotension, edema
- Treatment depends on severity but includes epinephrine, H1 antihistamines, corticosteroids, fluids
- Disposition is observation for 6-8 hours regardless of response to treatment due to risk of biphasic reaction
Anaphylaxis and anaphylactoid reactions docBhanu Sharadha
The document provides information from the European Anaphylaxis Taskforce on anaphylaxis and anaphylactoid reactions. It defines anaphylaxis and anaphylactoid reactions, discusses the evaluation and management of patients with a history of anaphylaxis, and covers various triggers of anaphylaxis including foods, insect stings, medications, and others. It emphasizes the importance of recognizing anaphylactic events rapidly and treating them promptly to prevent severe outcomes. Consultation with an allergy specialist is recommended to properly evaluate triggers and educate patients.
Si el envenenamiento es reconocido de forma temprana y reciben una atención medica adecuada, el pronostico es favorable.
La exposición a toxinas puede ocurrir por accidente (es decir, incidentes o interacciones medicamentosas) o intencionalmente (es decir, el abuso de sustancias o ingestas intencionales).
El envenenamiento depende de numerosos factores, como el tipo de sustancia, la dosis, el tiempo de exposición a la presentación a un centro de atención a la salud y el estado de salud preexistente del paciente.
The document discusses perioperative anaphylaxis including its incidence, pathophysiology, clinical presentation, differential diagnosis, common etiologies, and mimics. Some key points include:
- The incidence of perioperative anaphylaxis ranges from 1 in 1,250 to 1 in 20,000 procedures and has a mortality rate of 3-9%.
- Common triggers include neuromuscular blocking agents (50-70% of cases), antibiotics like cefazolin, latex, disinfectants like chlorhexidine, and dyes.
- Presentation can include isolated hypotension, bronchospasm, or cardiovascular collapse. Diagnosis may be delayed in anesthetized patients without typical skin signs
1) Serum tryptase measurements are important for investigating suspected cases of anaphylaxis during anaesthesia, but samples are often not collected properly or interpreted correctly.
2) Tryptase is released by mast cells during anaphylaxis and peaks 15-120 minutes after exposure, providing a marker for diagnosing reactions. However, multiple samples over 24 hours are needed for accurate interpretation.
3) Post-mortem tryptase measurements can also provide evidence of anaphylaxis, but require careful interpretation due to potential confounding factors from resuscitation and tissue degradation. Cut-offs used to indicate anaphylaxis in living patients do not directly apply post-mortem.
This document provides information on pediatric anaphylaxis, including its definition, epidemiology, etiology, pathophysiology, diagnosis, laboratory evaluation, management, treatment, and prevention. It discusses how anaphylaxis involves an immunoglobulin E-mediated immediate hypersensitivity reaction resulting in the release of chemical mediators. Common causes in children include foods, medications, insect stings, and vaccines. Symptoms often involve the skin, respiratory, gastrointestinal and cardiovascular systems. Diagnosis is based on clinical findings and management involves epinephrine and monitoring for biphasic reactions.
1) Allergic rhinitis (AR) is a common condition that affects millions of people in the US. It imposes a significant economic burden due to direct and indirect medical costs.
2) The diagnosis of AR can often be made based on a patient's symptoms of sneezing, rhinorrhea, nasal congestion, and watery eyes. It is important to differentiate between seasonal and perennial AR.
3) Other conditions like sinusitis and non-allergic rhinitis should also be considered in patients with nasal symptoms. Examination may reveal signs of conditions like asthma that commonly accompany AR.
Anaphylaxis & its public health (1).pptxoyinoje2004
This document discusses anaphylaxis, a potentially life-threatening allergic reaction. It notes that up to 20% of the world's population suffers from allergies. Anaphylaxis can progress through multiple stages and causes symptoms like low blood pressure, rash, nausea, vomiting, and airway obstruction. It is diagnosed through tests of the skin or blood. Risk factors include age, family history, and delaying epinephrine treatment. Causes include foods, medications, insects, latex, and exercise. Prevention involves avoiding allergens and always carrying epinephrine. Treatment requires promptly administering epinephrine and monitoring the patient in a hospital setting. Due to uncertainties around rates, anaphylaxis poses
This document provides guidance for assessing and referring patients experiencing suspected anaphylaxis. It recommends clinical assessment of patients after emergency treatment, including mast cell tryptase testing and observation periods. It also recommends referring patients to allergy specialist services and providing education on anaphylaxis, adrenaline auto-injectors, and warning signs before discharge. Implementing the guidelines may result in additional costs for specialist referrals but improve patient outcomes overall.
This case report describes a 25-year-old woman who experienced bronchospasm during anesthetic induction for cochlear implant surgery. After intubation with succinylcholine, she developed difficulty breathing, low carbon dioxide levels, and arterial desaturation. Epinephrine and fluids stabilized her cardiovascularly while wheezing and ventilation improved with bronchodilators and steroids. Testing ruled out allergy to induction agents but a possible non-IgE mediated reaction to succinylcholine. She recovered fully with treatment.
Terapia dello Shock Anafilattico - AdrenalinaFilippo Fassio
The document discusses guidelines for the assessment and management of anaphylaxis. It emphasizes the importance of promptly diagnosing anaphylaxis and administering epinephrine as the first-line treatment. While epinephrine is essential, the evidence for managing anaphylaxis is limited compared to other conditions. The guidelines focus on basic initial treatment that can be provided even in low-resource settings. Oxygen supplementation, intravenous fluids, and monitoring vitals are also recommended components of anaphylaxis management.
The document provides guidelines for antibiotic use in the ICU, including recommendations for empirical antibiotic choice, duration of therapy, and risk factors for multidrug-resistant pathogens. Key points addressed include empirically covering likely organisms like Staphylococcus aureus and Pseudomonas in severe CAP and HAP/VAP. Combination therapy and shorter courses are suggested when possible to reduce antibiotic resistance. Lower respiratory tract cultures should be obtained before but not delay treatment, and help determine if therapy can be stopped for negative cultures.
immunocap-isac-112-and-microtest-for-multiplex-allergen-testing-1053690256069Jane Green MA Ed
This document discusses multiplex allergen testing using ImmunoCAP ISAC 112 and Microtest. It provides background on allergy diagnosis and management. ImmunoCAP ISAC 112 can test for IgE antibodies to 112 components from 51 allergen sources using a single serum sample. Microtest uses microarray technology to measure IgE to 22 allergen extracts and 4 components. The document examines the clinical effectiveness and cost-effectiveness of these tests to help diagnose difficult-to-diagnose allergy cases. It finds currently insufficient evidence to recommend routine use but that further research is warranted.
World Allergy Week 2014 Anaphylaxis - When Allergies Can Be Severe and FatalWorldAllergy
World Allergy Week 2014 focuses on anaphylaxis. Anaphylaxis is a severe allergic reaction that is life-threatening and requires immediate treatment. Symptoms include throat swelling, rash, and low blood pressure. Common triggers include foods, medications, and insect bites/stings. Anaphylaxis is increasing globally and can be fatal if not treated properly with epinephrine. The World Allergy Organization provides resources and guidelines to educate about anaphylaxis prevention, treatment, and management.
This document summarizes guidelines for oxygen therapy in post-operative care. It recommends that oxygen therapy is an important part of recovery and can reduce post-operative complications. The summary outlines standards for best practice, such as all patients in recovery receiving oxygen according to local guidelines, and all high-risk patients who could benefit from post-operative oxygen being prescribed it and using it correctly. Audit indicators are proposed to measure adherence to these standards.
This is a presentation on anaphylaxis by Michael Rose. Michael is an anaesthetist in Sydney and a leading expert in the world of anaphylaxis. He talks about the basics and recent developments in this field - an area of critical care relevant to us all.
Anaphylaxis is a serious allergic reaction that is rapid in onset and can cause death. It involves multiple organ systems and its symptoms can include skin issues, respiratory distress, gastrointestinal symptoms and low blood pressure. It is most often triggered by foods, medications or insect stings. Diagnosis is clinical based on symptoms appearing shortly after exposure to a potential trigger. Treatment involves epinephrine, oxygen, fluids and monitoring vital signs. Patients are observed for potential biphasic reactions after initial treatment and provided anaphylaxis action plans and epinephrine autoinjectors upon discharge.
Airway and Anesthetic Management of the Traumatized Patient.pptxHadi Munib
The document discusses airway and anesthetic management of traumatized patients with maxillofacial injuries. It emphasizes the importance of securing the airway as the top priority during initial assessment and treatment. The initial airway assessment involves evaluating airway patency, ventilation, oxygenation, and vital signs. Specific factors that can complicate airway management in maxillofacial trauma patients are also reviewed, including mandibular fractures, dental injuries, hemorrhage, and soft tissue swelling. A thorough history including allergies, medications, and injury details is also important to guide appropriate anesthetic strategies.
This document provides guidance for a practical class on anesthesia for trauma patients. It begins with an overview of the importance of trauma anesthesia and discusses the initial assessment of trauma patients through a primary survey examining airway, breathing, circulation, disability and exposure. It provides details on establishing the airway for trauma patients while protecting the cervical spine, and assessing breathing and circulation. The document outlines the contents to be covered in the practical class, including anesthesia considerations for different types of trauma injuries.
The document discusses strategies for selecting antibiotics based on patient factors and the causative organism. It provides examples of rational antibiotic selection for a pregnant woman with a UTI and a hospitalized man on warfarin taking antibiotics for a UTI. The document also discusses antibiotic policies, pre-treatment considerations like duration and route of administration, superinfections, and different types of hypersensitivity tests including skin prick, intradermal, and patch testing. It validates the use of cephalosporin skin testing to predict immediate hypersensitivity but notes negative tests do not rule out the possibility of hypersensitivity upon intravenous administration.
This document provides guidance on oxygen therapy for children. It discusses hypoxaemia and its causes in neonates and children. It describes methods for detecting hypoxaemia, including clinical signs and pulse oximetry. It also covers sources of oxygen delivery such as oxygen concentrators and cylinders, and various delivery methods including for neonates and children. The document aims to increase awareness of oxygen therapy and improve its availability and appropriate use in low-resource settings.
Similar to Anaphylaxis and anaphylactoid reactions doc (20)
Portal hypertension is a condition where there is increased pressure in the portal venous system, which is a major vein that leads to the liver. It occurs when there is an obstruction to blood flow through the liver or an increase in blood flow. Common causes include liver cirrhosis and other chronic liver diseases. Symptoms include gastrointestinal bleeding, ascites, hepatic encephalopathy, and splenomegaly. It can be diagnosed through clinical findings, imaging studies, and direct measurement of portal pressures. Understanding the causes and pathophysiology of portal hypertension has led to new treatment approaches.
This document provides the ethical guidelines for biomedical research involving human participants in India. It begins with background on the development of international codes on medical ethics and human subjects research.
It then outlines the general statement of principles, stating that research must be directed towards increasing knowledge to benefit humanity while ensuring participants are not mere means to an end and are treated with dignity.
It also notes research must undergo evaluation at all stages, considering objectives, methods, and results, to safeguard participants.
The document provides an outline for a lecture on the anatomy and function of the nervous system. It begins with the basic divisions of the central nervous system versus the peripheral nervous system, and somatic versus autonomic systems. It then details the major structures of the brain including the hindbrain, midbrain, forebrain, cerebral cortex and its four lobes. The document also discusses the spinal cord, cranial nerves, and ventricular system at a high level.
The document provides guidance on developing an antibiotic policy and standard treatment guidelines for a hospital. It recommends establishing a multidisciplinary antibiotic management team to draft the policy. The team should review available evidence-based policies and guidelines and adapt them to the local context. The policy should provide recommendations for optimal antibiotic selection, dosage, duration and alternatives based on local antimicrobial resistance patterns. It should also address prophylactic use, identify gaps in evidence, and establish processes for regular review and updating the policy. The overall aim is to promote rational antibiotic use and reduce antimicrobial resistance.
American radiology accreditation reqmts 2013Bhanu Sharadha
The American College of Radiology has established a Diagnostic Imaging Centers of Excellence program to recognize facilities that demonstrate high quality imaging services through accreditation, participation in quality registries, and an on-site review. Facilities must be accredited in all modalities, participate in ACR registries, and undergo an on-site survey covering areas such as governance, safety, quality management, and patient rights. The survey team evaluates whether the facility meets standards for personnel, equipment, safety policies, and a quality improvement system. Facilities that pass this comprehensive assessment receive designation as a Diagnostic Imaging Center of Excellence.
This document provides an overview of Ayurveda, the traditional health science of India. It discusses that Ayurveda is one of the oldest medical systems, treating the whole person including body, mind and soul. The key concepts and principles of Ayurveda are explained, including the three doshas (biological elements), tissues, waste products, digestion and more. Diagnosis and treatment approaches like panchakarma are summarized. Overall, the document presents Ayurveda as a holistic medical system that focuses on balance, health promotion and treating the whole person.
Regulatory enviroment and clinical trials in south east asiaBhanu Sharadha
The document discusses regulatory environment and clinical trials in South East Asia. It provides information on:
1) The regulatory environment and drug registration processes vary across countries in the region but are becoming more harmonized through ASEAN initiatives. Requirements like GMP certificates and CPPs from countries of origin are common.
2) Approval timelines for new drug registration range from 6-24 months depending on the country. Singapore and Thailand typically approve within 6-12 months while Indonesia, Philippines, and Malaysia may take 12-24 months.
3) Clinical trial activity is growing in the region as large pharmaceutical companies conduct multi-center global trials to achieve faster patient recruitment for drug development. The large patient pools in
The document discusses quality and accreditation in Indian hospitals. It defines quality and outlines a quality improvement model involving plan-do-check-act cycles. It describes the roles of a quality steering committee and various quality indicators. NABH accreditation benefits all stakeholders by ensuring high quality care, patient safety, and continuous improvement. Accredited hospitals gain cost savings, consistent quality, and preferential treatment from customers and third parties.
This training manual provides guidance on size estimation methods for key at-risk populations in Asia and the Pacific. The goals are to build capacity for producing local and national size estimates. The workshop covers mapping, survey, and multiplier methods. It teaches how to assess existing data sources, prioritize additional data collection, and extrapolate estimates to the national level. Participants will learn skills for analyzing various size estimates and reconciling conflicting data. The exercises aim to help participants develop national size estimation plans tailored to their local contexts and data availability.
This document provides guidelines for estimating the size of populations most at risk for HIV. It outlines 10 steps for conducting population size estimates, including defining the population and area, reviewing available data, choosing an appropriate estimation method, collecting and analyzing data, and disseminating results. A variety of methods are described that use data from the at-risk population or general population, such as census, capture-recapture, multiplier, and network scale-up methods. The guidelines aim to help countries obtain reliable size estimates for surveillance, advocacy, program planning and evaluation.
Medication errors are a serious problem, causing over 1 million injuries and 100,000 deaths annually in the US. The elderly and children are most at risk. Common types of errors include administration of the wrong drug or wrong dosage, drug allergic reactions, narcotic overdoses, anticoagulant errors, insulin errors, drug interactions, pharmacy dispensing mistakes, inadequate warnings, infusion pump errors, incorrect pediatric dosages, confusing packaging, similar drug names, and improper abbreviations. Many errors are preventable through diligence and safety practices.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Anaphylaxis and anaphylactoid reactions doc
1. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
ANAPHYLAXIS and ANAPHYLACTOID REACTIONS.
CONTENTS
INTRODUCTION...............................................................................................................2
CONSULTATION WITH AN ANAPHYLAXIS SPECIALIST ..............................................2
DEFINITIONS OF ANAPHYLAXIS AND ANAPHYLACTOID EVENTS ............................3
EVALUATION AND MANAGEMENT OF PATIENTS WITH A HISTORY OF
ANAPHYLAXIS .................................................................................................................3
ALLERGENIC EXTRACTS AND IMMUNOTHERAPY......................................................3
FOODS .............................................................................................................................3
AVIAN-BASED VACCINES...............................................................................................4
INSECT STINGS AND BITES...........................................................................................4
LATEX...............................................................................................................................5
BETA LACTAM ANTIBIOTICS..........................................................................................5
ASA/NSAIDs .....................................................................................................................7
ANAPHYLACTOID REACTIONS TO RADIOGRAPHIC CONTRAST MATERIAL ...........7
INSULIN............................................................................................................................8
PROTAMINE.....................................................................................................................8
LOCAL ANESTHETICS ....................................................................................................8
ANAPHYLAXIS DURING GENERAL ANESTHESIA, THE INTRA-OPERATIVE PERIOD
AND THE POST-OPERATIVE PERIOD ...........................................................................9
PROGESTERONE............................................................................................................9
ANAPHYLACTOID REACTIONS TO INTRAVENOUS FLUORESCEIN ........................10
EXERCISE-INDUCED ANAPHYLAXIS ..........................................................................10
IDIOPATHIC ANAPHYLAXIS..........................................................................................11
PREVENTION OF ANAPHYLAXIS.................................................................................11
SUMMARY STATEMENTS.............................................................................................12
2. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
INTRODUCTION
It is imperative that all health care workers be familiar with the signs and symptoms of
anaphylactic events and the need for rapid diagnosis and treatment. These reactions, more
than any other type of life-threatening event, can be unexpected complications of medical
care. The difference between survival and death may ultimately depend on the physician’s
immediate recognition and diagnosis, followed by rapid and appropriate therapy.
Most of these reactions occur very rapidly, are often unanticipated and may have dramatic
effects. Even when there are mild initial symptoms the potential for progression to a severe
and even irreversible outcome must be appreciated. Any delay in recognizing the initial signs
and symptoms of anaphylaxis can result in mortality due to airway obstruction or vascular
collapse. There are a multitude of potential exposures in the patient’s environment that can
be implicated as precipitants of an anaphylactic or anaphylactoid event. Frequently, a
complex clinical presentation requires the involvement of the allergy-immunology specialist
who possesses particular training and skills to evaluate and appropriately treat these high
risk individuals.
The approaches to the diagnosis and management of anaphylaxis represent general
agreement of a panel of clinicians experienced in caring for patients with a history of
anaphylactic or anaphylactoid reactions, and has been reviewed and agreed upon by a large
number of individuals in the specialty of Allergy-Immunology. It is recognized that there are
different, although appropriate, ways of approaching the diagnosis and management of
anaphylaxis. In addition, particular features in individual patients necessitate a degree of
flexibility in therapeutic strategies. Where indicated, what was considered useful background
information has been discussed, but
an attempt was made to keep this document succinct and relevant to the diagnosis and
treatment of anaphylaxis and anaphylactoid reactions. With this goal in mind, only agents
which are general prototypes of anaphylaxis or anaphylactoid reactions are included. Thus a
number of specific drugs, such as antibiotics and biologic modalities are not discussed. Each
section of the document is organized into a text with preceding summary statements. These
summary statements reflect the editors’ consensus on the key aspects of each section. In
addition, algorithms for the evaluation and treatment of anaphylaxis and anaphylactoid
reactions, with appropriate annotations, are provided to facilitate clinical decisions.
The editors would like to thank those within the American Academy of Allergy, Asthma and
Immunology and the American College of Allergy, Asthma and Immunology who have
supported and encouraged this project, as well as the individuals who have donated their
time and energy to preparing the sections that form the foundation for this very important
document.
CONSULTATION WITH AN ANAPHYLAXIS SPECIALIST
· Anaphylaxis is a potentially life-threatening condition; recurrences must be prevented, if at
all possible.
· To maximize the chance of preventing recurrences of anaphylaxis, the aetiology should be
determined and the patient carefully instructed on measures for avoidance, as well as
emergency treatment.
· If future exposure is unavoidable, desensitization or allergen immunotherapy might be
considered.
· Consultation and cooperative interaction with the primary care provider, health care
providers treating anaphylaxis on an emergent basis, and the allergist-immunologist
maximizes the possibility of a successful outcome for the patient and the prevention of
subsequent life-threatening episodes
3. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
DEFINITIONS OF ANAPHYLAXIS AND ANAPHYLACTOID EVENTS
· Anaphylaxis is defined as an immediate systemic reaction due to rapid, IgE mediated
immune release of potent mediators from tissue mast cells and peripheral blood basophiles.
· Anaphylactoid reactions are immediate systemic reactions which mimic anaphylaxis but are
not caused by IgE-mediated immune responses.
· The temporal occurrence of these reactions is usually immediate but may be delayed
depending on the route of exposure. Occasionally, biphasic reactions may occur.
EVALUATION AND MANAGEMENT OF PATIENTS WITH A HISTORY OF
ANAPHYLAXIS
· A detailed history is important in the ultimate care of individuals who have had an
anaphylactic(toid) episode.
· Proper timing of laboratory studies, such as blood tests or urine assays, is important in
making these studies optimally useful.
· Effective treatment demands early recognition of the event.
· The possibility of anaphylaxis should be considered in any setting where medication or
biologicals are given, especially by injection.
· Medical facilities should have an established protocol for prompt therapy of anaphylaxis.
Supplies that are needed should be promptly available. Oxygen, aqueous epinephrine,
injectable antihistamines, I.V. glucocorticosteroids, oropharyngeal airway and supplies to
maintain IV fluid therapy are crucial.
· Phone numbers for paramedical rescue squads and ambulance services should be at hand.
· Protocols for the office staff and for patients should be available.
ALLERGENIC EXTRACTS AND IMMUNOTHERAPY
· The risk of fatal and non-fatal systemic reactions after administration of allergenic extract is
very low. The risk of such reactions after allergy skin testing is even lower.
· Risk factors for the development of systemic reactions to allergen immunotherapy may
include: 1) unstable steroid-dependent asthma; 2) a high level of allergic reactivity based on
diagnostic tests, usually immediate hypersensitivity skin tests; 3) a history of previous
systemic reactions to allergen immunotherapy; 4) starting a new vial of extract; 5) asthmatic
symptoms present immediately before receiving an injection of allergenic extract; 6)
concomitant treatment with beta adrenergic blocking agents, or ACE inhibitors; 7)
administration of pollen extracts; and 8) a rate of increase in the dose of allergenic extract
that is too rapid considering the patient's degree of hypersensitivity.
· Careful benefit: risk assessment of patients should be made in regard to performing allergy
skin testing and/or initiating allergen immunotherapy.
· Treatment of anaphylaxis resulting from administration of allergenic extracts is essentially
the same as the treatment of anaphylaxis from other causes.
· In rare cases of anaphylaxis, onset may be delayed for longer than an hour.
FOODS
· Severe food reactions have been reported to involve the gastrointestinal, cutaneous, ocular,
respiratory and cardiovascular systems.
· The greatest number of anaphylactic episodes in children have involved peanuts, other
legumes, true nuts (i.e. walnuts, pecans and others), fish, shellfish, milk and eggs. Cross-
reactivity with other foods in the same group is unpredictable. Condiments can also cause
anaphylaxis.
4. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
· Anaphylactic reactions to foods almost always occur immediately. Symptoms may then
subside only to recur several hours later.
· The most useful diagnostic tests include skin tests and food challenge. In vitro testing to
foods is an alternative, safe screening procedure.
· Double or single-blind placebo-controlled food challenges may be done in suspected food-
allergic patients in a medical facility by personnel experienced in performing the procedure
and prepared to treat anaphylaxis.
· Patient education about avoidance and management of accidental ingestion is important.
· Schools may present a special hazard for the food-allergic student. Epinephrine should be
available for use by the individuals in the school trained to respond to such a medical
emergency.
AVIAN-BASED VACCINES
· Adverse reactions to avian-based vaccines have been attributed to the egg protein in the
vaccine, as well as hydrolyzed gelatin, sorbitol and neomycin in some of the vaccines.
· True anaphylactic reactions to vaccines are rare, including those vaccines with minute
quantities of avian protein (measles, mumps, yellow fever and influenza).
· A careful history should be taken to document the symptoms and severity of prior allergic
reactions to egg protein, vaccines, and agents contained in vaccines such as gelatin.
· With a history of exquisite sensitivity (anaphylaxis) to egg protein, the utility of vaccine skin
testing to predict vaccine reactions remains controversial; however, it may be considered in
this high risk group, particularly if influenza or yellow fever vaccine are to be administered. If
the vaccine skin test is negative, the vaccine can be given.
· If a positive skin test to a vaccine is obtained, a desensitization protocol can be used to
administer the vaccine, although desensitization is not felt to be necessary by some experts.
Adverse reactions have been reported during skin testing and desensitization, so these
procedures should be performed by personnel trained to treat anaphylaxis.
INSECT STINGS AND BITES
· Insects from the Hymenoptera Order can cause systemic allergic reactions in sensitized
patients.
· Reactions to insect stings may include local, as well as skin, respiratory and/or vascular
reactions. There are no data that large local reactions predispose patients to systemic
reactions.
· Late reactions following insect stings include serum sickness-like syndromes, some of
which are not IgE mediated.
· Immediate hypersensitivity skin testing with venom to honey bee, wasp, yellow jacket,
yellow hornet and white faced hornet venoms is the most sensitive method for determining
specific IgE sensitivity in patients who have had anaphylactic reactions from stings of these
insects.
· Skin tests using whole body extract from fire ant and triatoma should be used to document
IgE sensitivity in patients with reactions to these types of insects.
· Immunotherapy with Hymenoptera venom for honey bee, yellow jacket, white faced hornet,
yellow hornet and wasp is extremely efficacious and is recommended for patients with
anaphylactic reactions following hymenoptera stings.
· Immunotherapy with Hymenoptera venom is currently recommended for a period of three to
five years, but the duration of venom immunotherapy should be individualized.
· The imported fire ants (IFA), Solenopsis invicta and Solenopsis richteri, are responsible for
significant allergic reactions. The typical result of an IFA sting is the development of a pruritic
wheal and flare at the site of the sting within 20 minutes. Six hours later a pustule forms
which continues to develop for the next 24 hours.
5. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
· Systemic reactions to IFA stings exhibit a spectrum which is similar to those reactions
following stings of other Hymenoptera species. From two to four percent of patients have
been reported to have serious systemic anaphylactic reactions following IFA stings.
· The diagnosis of IFA sting reactions includes a history of a typical fire ant mound in the
vicinity of the sting incident and the presence of a typical pustule at the sting site.
Documentation of specific IgE sensitivity to IFA is usually performed by skin testing with
imported fire ant whole body extract (IFA-WBE).
· Skin tests with IFA-WBE extracts are sensitive for determining specific IgE sensitivity in
patients who have had a history of generalized systemic anaphylactic reactions. In vitro
testing using whole body extract (WBE-RAST), is not as sensitive as the skin test for
determining IFA sensitivity.
· Triatoma, indigenous to the southwest, is a nocturnal blood-sucking arthropod whose bite
can produce anaphylaxis. Skin testing can be used to confirm the diagnosis and subsequent
reactions can be prevented by allergen immunotherapy. Other biting insects may
occasionally cause anaphylaxis.
LATEX
· Latex (rubber) hypersensitivity is a significant medical problem and three groups are at
higher risk of reactions: health care workers, children with spina bifida and genitourinary
abnormalities, and workers with occupational exposure to latex.
· To identify IgE mediated sensitivity, prick skin tests with latex extracts should be considered
for patients who are members of high risk groups or who have a clinical history of possible
latex allergy. Although a standardized, commercial skin test reagent for latex is not yet
available in the United States, many allergy centers have prepared latex extracts for clinical
testing. In vitro assays for IgE to latex may also be useful, although these tests are generally
less sensitive than skin tests.
· Patients with spina bifida (regardless of a history of latex allergy) and patients with a
positive history of latex allergy ideally should have all medical/surgical/dental procedures
performed in a latex-controlled environment.
· A latex-controlled environment is defined as an environment in which no latex gloves are
used in the room or surgical suite and no latex accessories (catheters, adhesives, tourniquet,
and anesthesia equipment) come into contact with the patient.
· In health care settings, general use of latex gloves having negligible allergen content,
powder-free latex gloves, and non-latex gloves and medical articles should be considered in
an effort to minimize exposure to latex allergen. Such a combined approach may minimize
latex sensitization of health care workers and patients and should reduce the risk of
inadvertent reactions to latex in previously sensitized individuals.
· Patients with a history of latex allergy by history or skin testing should wear a medical
identification bracelet and/or carry a medical identification card. If patients have a history of
anaphylaxis to latex, it may be important for them to carry epinephrine and antihistamines for
self-administration.
BETA LACTAM ANTIBIOTICS
· Penicillin is the most frequent cause of anaphylaxis in humans and has been estimated to
be responsible for 75% of anaphylactic deaths in the United States.
· Although allergic reactions may occur after administration of penicillin by any route,
parenteral administration is most likely to induce severe reactions such as anaphylaxis. Oral
administration appears considerably safer.
· Patients with a history of a prior penicillin reaction are six times more likely to experience a
reaction on subsequent exposure, compared with those without a previous history.
· Over 80% of patients with a history of allergy to penicillin do not have penicillin-specific IgE
antibodies as detected by skin testing.
6. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
· If a patient requires penicillin and has a past history of penicillin allergy, it is necessary to
skin test the patient for the presence of penicillin-specific IgE antibodies before assuming
that the patient will not be able to tolerate penicillin.
· Skin testing identifies patients who have IgE antibodies specific for penicillin, who, as a
result, may be at risk of an immediate reaction if given penicillin.
· Skin testing for penicillin does not predict the later development of IgE-mediated reactions
or reactions due to other immune mechanisms.
· IgE antibodies to minor determinants are most frequently implicated in anaphylactic
reactions to penicillin.
· Evaluation by RAST or ELISA testing does not reliably rule out allergy to penicillin because
of the insensitivity of the test and the lack of an appropriate minor determinant reagent.
· Patients with a history of possible allergic reaction to penicillin, who have a recommended
indication for penicillin treatment, should be skin tested.
· After anaphylaxis there is an interval of time during which skin test results may not be
reliable. This interval has been reported to vary from 1-2 weeks, or longer.
· Skin testing is generally not recommended for a patient with a history of an exfoliative
dermatitis, Stevens-Johnson syndrome or toxic epidermal necrolysis, caused by penicillin or
other beta-lactam medications.
· Patients with a positive family history, but no personal history of penicillin allergy do not
require penicillin skin testing, since they are generally not at risk of developing an allergic
reaction to penicillin.
· If skin testing for penicillin using major (penicilloyl) and minor determinants (penicillin G and
others) is negative, 97-99% of patients (depending on reagents used) will tolerate penicillin
administration without risk of an immediate reaction. Using the above reagents, and proper
technique by skilled personnel, serious reactions, including anaphylaxis and death, from skin
testing are extremely rare.
· If a patient has a positive history and a positive skin test for penicillin, there is a 50% or
greater chance of an immediate reaction if penicillin is given again.
· If the patient has a past history of an allergic reaction to penicillin, and the skin testing is
positive to either major or minor determinants, the patient should receive an alternative
antibiotic unless the indication for penicillin is clear. If administration of penicillin is mandatory
in this setting, desensitization is indicated.
· If the patient has a past history of allergy to penicillin and the skin testing is negative to
penicilloyl polylysine and penicillin G, there is a small chance that IgE antibodies to other
minor determinants not contained in penicillin G may be present.
· Administration of ampicillin and amoxicillin is associated with the development of
morbilliform rashes in 5-13% of patients. These patients should not be considered at risk of a
life-threatening reaction to penicillin, and therefore do not require skin testing. On the other
hand, if the rash to ampicillin or amoxicillin is urticarial or if the patient has a history of
anaphylaxis, the patient should undergo penicillin skin testing before a future course of
penicillin is given.
· Carbapenems (e.g., imipenem) should be considered cross-reactive with penicillin. The
monobactam, aztreonam, rarely cross-reacts with penicillin.
· Cephalosporins and penicillins have a common beta-lactam ring structure and varying
degrees of cross-reactivity have been reported. However, the risk of allergic reactions to
cephalosporins in penicillin-allergic patients appears to be low (less than 10%). First
generation cephalosporins may pose a greater risk than second or third generation
cephalosporins.
· If a patient has a questionable history of penicillin allergy and requires a cephalosporin,
penicillin skin testing can be considered to ensure the absence of penicillin-specific IgE
antibodies.
· If there is consideration of cephalosporin use in a patient who has a history of an
immediate-type reaction to penicillin, skin testing to major and minor determinants of
7. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
penicillin should be done to determine if the patient has penicillin-specific IgE antibodies. If
the skin testing is negative, the patient can receive a cephalosporin at no greater risk than
the general population.
· If there is consideration of cephalosporin use, in a patient with a history of penicillin allergy,
who has a positive skin test to penicillin, the physician's recommendations may include: 1)
administration of an appropriate alternative antibiotic; 2) a cautious graded challenge (test
dosing) with appropriate monitoring, recognizing that there is, at least, a 5% chance of
inducing an anaphylactic reaction; or 3) desensitization to the cephalosporin that is proposed
for use.
· Patients with a history of an IgE-mediated reaction to a cephalosporin, who require
penicillin, should undergo penicillin skin testing. If the tests are negative, they can receive
penicillin; if positive, they should either receive an alternative medication or undergo
desensitization to penicillin.
· If a patient with a past history of allergy to one cephalosporin requires another
cephalosporin, skin testing with the required cephalosporin can be done, recognizing that the
negative predictive value is unknown. If the skin test for the cephalosporin is positive, control
patients can be tested to determine if the positive response was due to irritation or was IgE-
mediated.
ASA/NSAIDs
· Aspirin (ASA) and non-steroidal anti-inflammatory drugs (NSAIDs) are associated with a
variety of non-IgE-mediated adverse effects. These include systemic reactions, such as
rhinoconjunctivitis, bronchospasm, urticaria, angioedema, and laryngeal edema.
· There is no definitive skin or in-vitro test to identify patients who are intolerant to ASA or
NSAIDs. On the other hand, carefully performed oral ASA/NSAID challenges can be useful in
making a more definitive diagnosis.
· Once a diagnosis has been made, avoidance is essential in preventing life-threatening
reactions to these agents. This requires educating the patient about combination products
(including over-the-counter medications) containing ASA or NSAIDs.
· Allergy/Immunology specialists are frequently asked to clarify the risk of reactions to
ASA/NSAIDs and to devise a strategy for dealing with these therapeutic dilemmas.
· It may be useful to refer a patient suspected of being intolerant to ASA or a NSAID to an
allergist-immunologist and/or center where oral aspirin/NSAID challenges are performed
routinely in a well equipped medical facility, because of the possibility of life- threatening
reactions that can occur from such challenges.
· If ASA/NSAID challenge is positive, pharmacologic desensitization and continued treatment
with ASA or NSAIDs can be utilized if there is a medical indication for this type of medication.
ANAPHYLACTOID REACTIONS TO RADIOGRAPHIC CONTRAST
MATERIAL
· Anaphylactoid reactions to radiocontrast material (RCM) can occur after intravascular
administration and during hysterosalpingograms, myelograms, and retrograde pyelograms.
· Anaphylactoid reactions to RCM are clinically indistinguishable from IgE-mediated
immediate hypersensitivity anaphylactic reactions, although they do not appear to be
associated with IgE or any other type of immunologic reaction.
· The treatment of anaphylactoid reactions to RCM is not different than the treatment of
anaphylactic reactions caused by allergen-IgE interaction and resultant mast cell mediator
release.
· Patients who have experienced previous anaphylactoid reactions from the administration of
radiocontrast material (RCM) are at risk for a repeat reaction. Estimates of this risk range
8. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
from 16-44% for procedures with high osmolality RCM. Therefore, the physician should
consider other alternatives in managing such patients rather than procedures which require
readministration of RCM.
· With pretreatment and the use of lower osmolar RCM the risk of repeat anaphylactoid
reactions is reduced to approximately 1%.
· Pretreatment regimens for prevention of repeat anaphylactoid reactions have consisted of
oral glucocorticosteroids, H1 and H2 antihistamines and other medications such as
ephedrine.
INSULIN
· In general, the degree of insulin immunogenicity is in the following order: bovine > porcine >
human. Although anaphylactic reactions to human insulin produced by recombinant DNA
technology, are rare, they can occur.
· Insulin-induced anaphylaxis is characterized by the same manifestations as anaphylaxis
from other causes.
· Patients are more likely to develop anaphylaxis from insulin administration if therapy is
interrupted.
· Skin testing with insulin can aid in making the diagnosis of insulin-induced anaphylaxis. In
addition, skin testing can be used to select the least allergenic insulin for administration to
patients who have a history of immediate hypersensitivity reactions to insulin, yet require
insulin.
· Patients with a history of anaphylaxis to insulin can be desensitized to insulin if no
alternative medications exist to treat their disease.
PROTAMINE
· Intravenous administration of protamine, a polycationic protein used to reverse heparin
anticoagulation, may cause anaphylaxis as well as transient elevations in pulmonary artery
pressure and/or cardiovascular collapse.
· The pathogenesis of these acute reactions has not been proven but both non-immune and
immune (IgE) mechanisms have been reported.
· Patients who previously required protamine-containing insulin or intravenous protamine are
at significantly increased risk for developing anaphylaxis and other adverse reactions from
intravenous protamine.
· Although intracutaneous tests with protamine may be helpful in identifying a possible IgE
mediated response in selected cases, these tests must be interpreted with caution because
they do not necessarily predict clinical sensitivity, and do not identify all patients at risk.
· A variety of alternative approaches may be considered to avoid the need for protamine
reversal of heparinization. Several alternative agents may be used for heparin reversal, but
these are not readily available on an emergency basis. For patients at high risk for protamine
reactions, one should attempt to obtain one of the alternative reversal agents prior to the
procedure which requires heparin anticoagulation.
· Although pre-medication with antihistamines and corticosteroids may be considered in an
effort to reduce protamine reactions, there are no controlled trials that have demonstrated
that pre-medication is effective in this setting.
LOCAL ANESTHETICS
· Anaphylactic reactions to local anesthetics or constituents of local anesthetics have been
reported, although IgE-mediated systemic anaphylaxis to these agents is rare.
· Local anesthetics are classified into groups including esters (aminobenzoate and benzoic
acid subtypes), amides, ethers, and ketones.
9. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
· Provocative (graded) dose challenge should be considered when the cause of a reaction is
unknown, or proof of safety is required before administration.
· Reactions to additives such as parabens or sulfites may occur but are rare and routine
testing with these substances is not recommended.
· In patients who have had reactions to an ester type local anesthetic, an amide should be
considered for provocative (graded) dose testing. If the patient had a reaction to an amide,
another amide might be considered, since cross reactivity among amides has not been
documented.
ANAPHYLAXIS DURING GENERAL ANESTHESIA, THE INTRA-
OPERATIVE PERIOD AND THE POST-OPERATIVE PERIOD
· The incidence of generalized anaphylactic reactions during anesthesia has been reported to
range from 1 in 4,000 to 1 in 25,000. Anaphylaxis, during anesthesia, can present as
cardiovascular collapse, airway obstruction, flushing and/or edema of the skin.
· It may be difficult to differentiate between immune and non-immune mast cell mediated
reactions and pharmacologic effects from the variety of medications administered during
general anesthesia.
· Thiopental allergy has been documented by skin tests.
· Neuromuscular blocking agents such as succinylcholine can cause non-immunologic
histamine release, but there have been reports of IgE mediated mechanisms in some cases.
· Reactions to opioid analgesic are usually due to direct mast cell mediator release rather
than IgE dependent mechanisms.
· Antibiotics which are administered perioperatively can cause immunologic or non-
immunologic generalized reactions.
· Protamine can also cause severe systemic reactions via IgE-mediated or non-immunologic
mechanisms.
· Latex is a potent allergen and IgE mediated reactions to latex during anesthesia have been
clearly documented. Patients with multiple surgical procedures (e.g. spina bifida patients)
and health care workers are at greater risk of latex sensitization.
· Precautions for latex sensitive patients include avoiding the use of latex gloves and latex
blood pressure cuffs as well as latex intravenous tubing ports and rubber stoppers from
medication vials.
· Ethylene oxide anaphylactic reactions have been reported particularly in patients who have
exposure to hemodialysis or who are undergoing plasmapheresis.
· Blood transfusions can elicit a variety of systemic reactions, some of which may be IgE-
mediated or mediated through other immunologic mechanisms.
· Methylmethacrylate (bone cement) has been associated with hypotension and various
systemic reactions, although no allergic mechanism has yet been documented.
· The evaluation of allergic reactions to medications used during anesthesia can include skin
testing to a variety of anesthetic agents.
· The management of anaphylactic reactions which occur during general anesthesia is similar
to the management of anaphylaxis in other situations.
PROGESTERONE
· Unexplained episodes of anaphylaxis may be due to unusual reactivity to progesterone.
Anaphylactic symptoms tend to be premenstrual but may occur anytime during the menstrual
cycle. In one report, lactation caused complete remission of symptoms.
· The pathogenesis of this disorder is unknown but laboratory studies have shown that
progesterone may either induce histamine release from basophils directly or make mast cells
more susceptible to other mast cell degranulators.
· Treatment options include a leutinizing hormone releasing hormone (LHRH) agonist analog
(e.g., Naferelin) or oophorectomy in particularly resistant cases.
10. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
· A differential consideration that may be confused with progesterone-induced anaphylaxis is
catemenial anaphylaxis not related to progesterone reactivity. Anaphylactic symptoms occur
during menses, and full recovery after oophorectomy has been reported.
ANAPHYLACTOID REACTIONS TO INTRAVENOUS FLUORESCEIN
· Anaphylactoid reactions may occur after intravenous administration of fluorescein, a yellow
water-soluble dibasic xanthine dye used in the diagnosis and detection of chorioretinal
lesions.
· The most common adverse reactions to intravenous fluorescein are nausea and vomiting
but anaphylactoid reactions resulting in death have also been reported. Although increase in
plasma histamine and decrease in various complement components have been described
after anaphylactoid reactions, the pathogenesis of these reactions is not known.
· Prophylactic regimens similar to those used for radiocontrast media should be considered in
patients who have had a previous anaphylactoid reaction and in whom use of intravenous
fluorescein dye is indicated. However, these have not been used in sufficient numbers of
patients to provide a definitive recommendation.
SEMINAL FLUID
· Anaphylaxis due to human seminal fluid has been shown to be due to IgE mediated
sensitization by proteins of varying molecular weight.
· History of atopic disease is the most consistent risk factor. However, anecdotal case reports
have been associated with gynecologic surgery, injection of anti-Rh immunoglobulin and the
postpartum period.
· The diagnosis confirmed by either skin or in vitro tests for serum-specific IgE using proper
reagents obtained from fractionation of seminal fluid components.
· Prevention of reactions to seminal fluid can be accomplished by use of barrier condoms.
· Immunotherapy to properly fractionated seminal fluid proteins has been universally
successful in preventing anaphylaxis to seminal fluid, provided the sensitizing seminal fluid
fractions are used as immunogens.
EXERCISE-INDUCED ANAPHYLAXIS
· Exercise-induced anaphylaxis is a unique form of physical allergy. Initial symptoms typically
include fatigue, diffuse warmth, pruritus, erythema and urticaria, with progression to
angioedema, gastrointestinal symptoms, laryngeal edema and/or vascular collapse.
· Factors that have been associated with exercise-induced anaphylaxis include medications,
e.g. aspirin/other nonsteroidal anti-inflammatory agents or food ingestion prior to exercise.
· Patients with exercise-induced anaphylaxis may have a higher incidence of personal and/or
family history of atopy.
· Exercise-induced anaphylaxis should be distinguished from other exercise-associated
syndromes, such as cholinergic urticaria and exercise-induced asthma.
· Medications used prophylactically are generally not useful in preventing exercise-induced
anaphylaxis.
· Exercise should be discontinued at the onset of symptoms of exercise-induced anaphylaxis
and for some patients, exercise should be avoided in the immediate post-prandial period (4-6
hours after eating).
· The emergency management of exercise-induced anaphylaxis is the same as the treatment
of anaphylaxis from other causes.
· Patients with exercise-induced anaphylaxis should carry epinephrine and ideally should
wear and/or carry Medic Alert identification denoting their condition.
11. This information has been provided by the European Anaphylaxis Taskforce
Please visit http://www.anaphylaxis.eu for more information on this organisation.
This information has been derived from the internet on Monday, 16 October 2006
The European Anaphylaxis Taskforce
Making life better for those at risk of life threatening allergic reactions
IDIOPATHIC ANAPHYLAXIS
· Patients who develop idiopathic anaphylaxis present with the same constellation of
symptoms that are seen in other types of anaphylactic/anaphylactoid reactions.
· Patients with idiopathic anaphylaxis should receive intensive evaluation, including a
meticulous history with careful analysis of events surrounding the development of episodes
of anaphylaxis.
· Clinical evaluation may indicate the need for specific laboratory studies which may help to
exclude an underlying systemic disorder, e.g. systemic mast cell disease or hereditary
angioneurotic edema. Selective testing for specific IgE antibodies and carefully controlled
challenge procedures may occasionally help to establish an etiology for recurrent episodes of
anaphylaxis.
· The acute treatment of idiopathic anaphylaxis is the same as the treatment of other types of
anaphylactic/anaphylactoid reactions. Various protocols have been developed for the
prevention of idiopathic anaphylaxis, but the treatment, e.g. corticosteroids, beta agonists,
antihistamines, will depend on each individual patient's manifestations.
· Education and support of patients with idiopathic anaphylaxis is an essential part of the
management program.
PREVENTION OF ANAPHYLAXIS
· Major risk factors for recurrence of anaphylaxis include a prior history of such reactions,
beta-adrenergic blocker, or ACE inhibitor therapy and patients who have the multiple
antibiotic sensitivity syndrome. Atopic background may be a risk factor for venom and latex-
induced anaphylaxis and possibly anaphylactoid reactions to radiographic contrast material,
but not for anaphylactic reactions to many medications.
· Avoidance measures are successful if future exposure to drugs, foods, additives or
occupational allergens can be prevented. Avoidance of stinging and biting insects is also
possible in many cases. Prevention of systemic reactions during allergen immunotherapy are
dependent on the specific circumstances involved.
· Avoidance management should be individualized, taking into consideration factors such as
age, activity, occupation, hobbies, residential conditions, access to medical care and the
patient’s level of anxiety.
· Pharmacologic prophylaxis should be utilized to prevent recurrent anaphylactoid reactions
to radiographic contrast material, and to fluorescein as well as to prevent idiopathic
anaphylaxis. Pretreatment with glucocorticosteroids and antihistamines markedly reduces
the occurrence of subsequent reactions.
· Allergen immunotherapy with the appropriate stinging insect venom should be
recommended for patients with systemic sensitivity to stinging insects because this treatment
is highly (90-98%) effective.
· Desensitization to medications that are known to have caused anaphylaxis can be effective.
In most cases, the effect of desensitization is temporary and if the medication is required
sometime in the future, the desensitization process must be repeated. Oral graded challenge
to medications such as aspirin, sulfasalazine or allopurinol may restore drug tolerance as
long as the medication is administered on a continuous basis.
· Patient education may be the most important preventive strategy. Patients must be carefully
instructed about hidden allergens, cross-reactions to various allergens, unforeseen risks
during medical procedures and when and how to use self-administered epinephrine.
Physicians should educate patients about the risks of future anaphylaxis, as well as the
benefits of avoidance measures